HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers

Experimental Cell Research

Volumn 312, Issue 9, 2006, Pages 1590-1597

  Vulcano, Francesca ^a   Ciccarelli, Carmela ^b   Mattia, Gianfranco ^a   Marampon, Francesco ^b   Macioce, Giampiero ^a   Milazzo, Luisa ^a   Pascuccio, Massimiliano ^a   Zani, Bianca M ^b   Giampaolo, Adele ^a   Hassan, Hamisa J ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cell adhesion; ERK1 2; GpIIb IIIa; GpIIIa; HDAC inhibition; Megakaryocytic differentiation; UT 7 cell line; VPA

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CD61 ANTIGEN; CELL MARKER; FIBRINOGEN RECEPTOR; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; VALPROIC ACID;

ACETYLATION; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; UPREGULATION;

EID: 33646140563     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.01.017     Document Type: Article

References (37)

1. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
2. Lee D.Y., Hayes J.J., Pruss D., and Wolffe A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72 (1993) 73-84
3. Cress W.D., and Seto E. Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184 (2000) 1-16
4. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo C.F., Nervi C., Pelicci P.G., and Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20 (2001) 6969-6978
5. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., and Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276 (2001) 36734-36741
6. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265 (1990) 17174-17179
7. Kosugi H., Towatari M., Hatano S., Kitamura K., Kiyoi H., Kinoshita T., Tanimoto M., Murate T., Kawashima K., Saito H., and Naoe T. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia 13 (1999) 1316-1324
8. Maeda T., Towatari M., Kosugi H., and Saito H. Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells. Blood 96 (2000) 3847-3856
9. Gurvich N., Tsygankova O.M., Meinkoth J.L., and Klein P.S. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 64 (2004) 1079-1086
10. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., and Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276 (2001) 31674-31683
11. Pearson G., Robinson F., Beers G.T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
12. Cowley S., Paterson H., Kemp P., and Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77 (1994) 841-852
13. Mauro A., Ciccarelli C., De Cesaris P., Scoglio A., Bouche M., Molinaro M., Aquino A., and Zani B.M. PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J. Cell Sci. 115 (2002) 3587-3599
14. Racke F.K., Lewandowska K., Goueli S., and Goldfarb A.N. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J. Biol. Chem. 272 (1997) 23366-23370
15. Sevinsky J.R., Whalen A.M., and Ahn N.G. Extracellular signal-regulated kinase induces the megakaryocyte GPIIb/CD41 gene through MafB/Kreisler. Mol. Cell. Biol. 24 (2004) 4534-4545
16. Rojnuckarin P., Drachman J.G., and Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood 94 (1999) 1273-1282
17. Fichelson S., Freyssinier J.M., Picard F., Fontenay-Roupie M., Guesnu M., Cherai M., Gisselbrecht S., and Porteu F. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood 94 (1999) 1601-1613
18. Guerriero R., Mattia G., Testa U., Chelucci C., Macioce G., Casella I., Samoggia P., Peschle C., and Hassan H.J. Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood 97 (2001) 2587-2595
19. Miyazaki R., Ogata H., and Kobayashi Y. Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation. Ann. Hematol. 80 (2001) 284-291
20. Komatsu N., Nakauchi H., Miwa A., Ishihara T., Eguchi M., Moroi M., Okada M., Sato Y., Wada H., and Yawata Y. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res. 51 (1991) 341-348
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
22. Mattia G., Vulcano F., Milazzo L., Barca A., Macioce G., Giampaolo A., and Hassan H.J. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34(+) cells are correlated with different levels of platelet release. Blood 99 (2002) 888-897
23. Porteu F., Rouyez M.C., Cocault L., Benit L., Charon M., Picard F., Gisselbrecht S., Souyri M., and Dusanter-Fourt I. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol. Cell. Biol. 16 (1996) 2473-2482
24. Bug G., Gul H., Schwarz K., Pfeifer H., Kampfmann M., Zheng X., Beissert T., Boehrer S., Hoelzer D., Ottmann O.G., and Ruthardt M. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res. 65 (2005) 2537-2541
25. De Felice L., Tatarelli C., Mascolo M.G., Gregorj C., Agostini F., Fiorini R., Gelmetti V., Pascale S., Padula F., Petrucci M.T., Arcese W., and Nervi C. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res. 65 (2005) 1505-1513
26. Gesundheit B., Kirby M., Lau W., Koren G., and Abdelhaleem M. Thrombocytopenia and megakaryocyte dysplasia: an adverse effect of valproic acid treatment. J. Pediatr. Hematol. Oncol. 24 (2002) 589-590
27. Kishi T., Fujita N., Kawaguchi H., Ishimae M., Watanabe K., and Tanaka T. Bone marrow suppression induced by high dose valproic acid. Arch. Dis. Child. 71 (1994) 153-155
28. Hsieh J., Nakashima K., Kuwabara T., Mejia E., and Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. U. S. A 101 (2004) 16659-16664
29. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370 (2003) 737-749
30. Lind S.E., Yin H.L., and Stossel T.P. Human platelets contain gelsolin. A regulator of actin filament length. J. Clin. Invest. 69 (1982) 1384-1387
31. Han J.W., Ahn S.H., Park S.H., Wang S.Y., Bae G.U., Seo D.W., Kwon H.K., Hong S., Lee H.Y., Lee Y.W., and Lee H.W. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res. 60 (2000) 6068-6074
32. Kwon H.J., Yoshida M., Nagaoka R., Obinata T., Beppu T., and Horinouchi S. Suppression of morphological transformation by radicicol is accompanied by enhanced gelsolin expression. Oncogene 15 (1997) 2625-2631
33. Porter R.M., Holme T.C., Newman E.L., Hopwood D., Wilkinson J.M., and Cuschieri A. Monoclonal antibodies to cytoskeletal proteins: an immunohistochemical investigation of human colon cancer. J. Pathol. 170 (1993) 435-440
34. Witt O., Sand K., and Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95 (2000) 2391-2396
35. Witt O., Monkemeyer S., Ronndahl G., Erdlenbruch B., Reinhardt D., Kanbach K., and Pekrun A. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 101 (2003) 2001-2007
36. Kramer O.H., Zhu P., Ostendorff H.P., Golebiewski M., Tiefenbach J., Peters M.A., Brill B., Groner B., Bach I., Heinzel T., and Gottlicher M. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 22 (2003) 3411-3420
37. Insinga A., Monestiroli S., Ronzoni S., Gelmetti V., Marchesi F., Viale A., Altucci L., Nervi C., Minucci S., and Pelicci P.G. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat. Med. 11 (2005) 71-76